Globus Medical (NYSE:GMED) Price Target Raised to $92.00 at Stifel Nicolaus
Globus Medical (NYSE:GMED – Free Report) had its price target raised by Stifel Nicolaus from $80.00 to $92.00 in a research note released on Wednesday morning,Benzinga reports. They currently have a buy rating on the medical device company’s stock. A number of other equities analysts have also issued reports on GMED. Wells Fargo & Company […]
10 Nov 07:58 · The Cerbat Gem